Laurion Capital Management LP Vigil Neuroscience, Inc. Transaction History

Laurion Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 14, 2023	SELL	$8.11 - $10.54 $247,444 - $321,585	-30,511 Reduced 23.43%	99,689 $937,000
Q2 2022 Aug 15, 2022	BUY	$2.23 - $7.81 $290,346 - $1.02 Million	130,200 New	130,200 $336,000

26.3M

Ticker VIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,268,600
Market Cap $94.1M
Description
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.